Funding for this research was provided by:
MSD France (EPICORL)
Received: 7 February 2019
Accepted: 10 July 2019
First Online: 25 July 2019
Ethics approval and consent to participate
: The EPICORL study was approved by the French National Commission for Data Protection (CNIL DE-2015-025) who granted access to the French National Hospital Discharge database for the years 2008 to 2013.
: All authors have completed the ICMJE Competing Interest form and declare that: MS is the founder/CEO of Translational Health Economics Network (THEN), Paris, France that received research grants from MSD France as well as Abbvie, Gilead and Novartis, outside and unrelated to the submitted work. SL has declared no conflicts of interest.